Summary
Pharmacom NOLT 300, manufactured by Pharmacom Labs, was independently analyzed by SIMEC AG to verify its labeled claims, composition, and sterility. The product contains a blend of nandrolone esters, as indicated on the label. However, the analysis revealed that two listed ingredients, Nandrolone Propionate and Nandrolone Laurate, were not detected. The remaining components, Nandrolone Phenylpropionate and Nandrolone Decanoate, exceeded their respective labeled claims. Microbiological tests confirmed that the product is sterile and free from contamination.
Detailed Report
Product Overview
- Manufacturer: Pharmacom Labs
- Product Name: NOLT 300
- Batch Number: Not specified
- Expiration Date: September 2017
- Delivery Method: Injectable
Sample Acquisition and Testing
- Test Report Number: C 67093
- Testing Ordered: 28 February 2018
- Sample Received: 28 February 2018
- Analysis Conducted By: SIMEC AG
- Product Submitted By: AnabolicLab.com
- Analysis Paid For By: AnabolicLab.com
Testing Results
Compound | Specification (Label Claim) | Measured Concentration | Accuracy | Variance | Compliance |
---|---|---|---|---|---|
Nandrolone Propionate | 60 mg/ml | Not detected | 0% | -100% | No |
Nandrolone Phenylpropionate | 60 mg/ml | 119.0 mg/ml | 198.33% | +98.33% | Yes |
Nandrolone Decanoate | 90 mg/ml | 173.5 mg/ml | 192.78% | +92.78% | Yes |
Nandrolone Laurate | 90 mg/ml | Not detected | 0% | -100% | No |
Microbiological Testing | Result | Specification |
---|---|---|
TAMC | <1 KBE/ml | Complies |
TYMC | <1 KBE/ml | Complies |
Evaluation of Independent Testing
The analysis reveals significant discrepancies between the labeled claims and actual content. While Nandrolone Phenylpropionate and Nandrolone Decanoate were present at much higher concentrations than claimed, Nandrolone Propionate and Nandrolone Laurate were entirely absent. These inconsistencies highlight potential quality control issues during manufacturing. On a positive note, sterility tests confirmed the product’s safety in terms of microbial contamination.
Conclusion
Pharmacom NOLT 300 shows a lack of consistency with its label claims. Two key ingredients were not detected, while the remaining esters exceeded their labeled concentrations significantly. This variability underscores the need for consistent manufacturing practices and further independent testing across multiple batches. Despite these findings, the product demonstrated microbiological sterility.
Disclaimer
This report is published for educational and harm reduction purposes. The results apply exclusively to the tested batch and may not represent other batches of the same product. Readers are encouraged to compare these findings with independent third-party testing for broader insights.
No microbiological contamination was detected.
Discuss the Pharmacom Labs PHARMA Nolt 300 lab test results on the AnabolicLab Forum.
(The following images are photographs of the actual product that was submitted for testing.)